{"entity":{"type":"insider","cik":"0001358266","url":"/insider/0001358266","json_url":"/insider/0001358266.json","name":"Yeramian Patrick D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":6,"first":"2023-01-10","last":"2024-01-11","span_basis":"filed_date"},"name_variants":[{"name":"Yeramian Patrick D","source":"filing","n_filings":6,"first_seen":"2023-01-10","last_seen":"2024-01-11"}],"transactions":[{"id":2948137,"accession":"0000950170-24-003974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-003974","line_url":"/filing/0000950170-24-003974#line-1","is_derivative":false,"issuer_cik":"0001358266","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001358266","owner_cik":"0001358266","owner_name":"Yeramian Patrick D","owner_url":"/insider/0001358266","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2812.0,"shares_display":"2,812","price_per_share":16.3281,"price_display":"16.33","price_state":"stated","total_value":45914.6172,"total_display":"45,914.62","shares_owned_after":205605.0,"shares_owned_after_display":"205,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-11","scope":"insider"},{"id":8064604,"accession":"0000950170-23-022775","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-23-022775","line_url":"/filing/0000950170-23-022775#line-3","is_derivative":false,"issuer_cik":"0001358266","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001358266","owner_cik":"0001358266","owner_name":"Yeramian Patrick D","owner_url":"/insider/0001358266","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11965.0,"shares_display":"11,965","price_per_share":29.0312,"price_display":"29.03","price_state":"stated","total_value":347358.308,"total_display":"347,358.31","shares_owned_after":208417.0,"shares_owned_after_display":"208,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-17","scope":"insider"},{"id":8351145,"accession":"0000899243-23-011461","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-23-011461","line_url":"/filing/0000899243-23-011461#line-4","is_derivative":false,"issuer_cik":"0001358266","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001358266","owner_cik":"0001358266","owner_name":"Yeramian Patrick D","owner_url":"/insider/0001358266","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49279.0,"shares_display":"49,279","price_per_share":30.5335,"price_display":"30.53","price_state":"stated","total_value":1504660.3465,"total_display":"1,504,660.35","shares_owned_after":208717.0,"shares_owned_after_display":"208,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-19","scope":"insider"},{"id":8351138,"accession":"0000899243-23-011461","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-23-011461","line_url":"/filing/0000899243-23-011461#line-3","is_derivative":false,"issuer_cik":"0001358266","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001358266","owner_cik":"0001358266","owner_name":"Yeramian Patrick D","owner_url":"/insider/0001358266","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":30.94,"price_display":"30.94","price_state":"stated","total_value":9282.0,"total_display":"9,282.00","shares_owned_after":208417.0,"shares_owned_after_display":"208,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-19","scope":"insider"},{"id":9205347,"accession":"0000899243-23-009600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-009600","line_url":"/filing/0000899243-23-009600#line-1","is_derivative":false,"issuer_cik":"0001358266","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001358266","owner_cik":"0001358266","owner_name":"Yeramian Patrick D","owner_url":"/insider/0001358266","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52211.0,"shares_display":"52,211","price_per_share":31.8485,"price_display":"31.85","price_state":"stated","total_value":1662842.0335,"total_display":"1,662,842.03","shares_owned_after":201666.0,"shares_owned_after_display":"201,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-24","scope":"insider"},{"id":9205346,"accession":"0000899243-23-009600","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-009600","line_url":"/filing/0000899243-23-009600#line-2","is_derivative":false,"issuer_cik":"0001358266","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001358266","owner_cik":"0001358266","owner_name":"Yeramian Patrick D","owner_url":"/insider/0001358266","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2416.0,"shares_display":"2,416","price_per_share":32.4331,"price_display":"32.43","price_state":"stated","total_value":78358.3696,"total_display":"78,358.37","shares_owned_after":199250.0,"shares_owned_after_display":"199,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-24","scope":"insider"},{"id":8669330,"accession":"0000899243-23-009178","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-23-009178","line_url":"/filing/0000899243-23-009178#line-3","is_derivative":false,"issuer_cik":"0001358266","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001358266","owner_cik":"0001358266","owner_name":"Yeramian Patrick D","owner_url":"/insider/0001358266","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52211.0,"shares_display":"52,211","price_per_share":31.8485,"price_display":"31.85","price_state":"stated","total_value":1662842.0335,"total_display":"1,662,842.03","shares_owned_after":152088.0,"shares_owned_after_display":"152,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-20","scope":"insider"},{"id":8669327,"accession":"0000899243-23-009178","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-009178","line_url":"/filing/0000899243-23-009178#line-2","is_derivative":false,"issuer_cik":"0001358266","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001358266","owner_cik":"0001358266","owner_name":"Yeramian Patrick D","owner_url":"/insider/0001358266","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2416.0,"shares_display":"2,416","price_per_share":32.4331,"price_display":"32.43","price_state":"stated","total_value":78358.3696,"total_display":"78,358.37","shares_owned_after":149672.0,"shares_owned_after_display":"149,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-20","scope":"insider"},{"id":8694137,"accession":"0000899243-23-001526","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-001526","line_url":"/filing/0000899243-23-001526#line-2","is_derivative":false,"issuer_cik":"0001358266","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001358266","owner_cik":"0001358266","owner_name":"Yeramian Patrick D","owner_url":"/insider/0001358266","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1405.0,"shares_display":"1,405","price_per_share":36.0789,"price_display":"36.08","price_state":"stated","total_value":50690.8545,"total_display":"50,690.85","shares_owned_after":204928.0,"shares_owned_after_display":"204,928","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-06","filed_date":"2023-01-10","scope":"insider"},{"id":8694133,"accession":"0000899243-23-001526","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-001526","line_url":"/filing/0000899243-23-001526#line-1","is_derivative":false,"issuer_cik":"0001358266","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001358266","owner_cik":"0001358266","owner_name":"Yeramian Patrick D","owner_url":"/insider/0001358266","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":629.0,"shares_display":"629","price_per_share":36.7888,"price_display":"36.79","price_state":"stated","total_value":23140.1552,"total_display":"23,140.16","shares_owned_after":204299.0,"shares_owned_after_display":"204,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-06","filed_date":"2023-01-10","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001658551","name":"Amylyx Pharmaceuticals, Inc.","url":"/issuer/0001658551","role":"Officer (Chief Medical Officer)","n_filings":6,"first_seen":"2023-01-10","last_seen":"2024-01-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001358266","retrieved_at":"2026-08-20T19:25:52+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}